Abbott (ABT)
91.07
+0.29 (0.32%)
Upcoming Events
Latest Headlines
Form SD ABBOTT LABORATORIES
May 27, 2026 4:48 PM - SEC Filing
Abbott receives CE Mark for dual glucose-ketone diabetes sensor
May 27, 2026 9:01 AM - StreetInsider
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
May 27, 2026 9:01 AM - PR NewsWire
American Cancer Society reaffirms Abbott colorectal screening tests
May 27, 2026 7:02 AM - StreetInsider
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
May 27, 2026 7:01 AM - PR NewsWire
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
May 26, 2026 9:00 AM - PR NewsWire
Form 144 ABBOTT LABORATORIES Filed by: Alpern Robert J
May 15, 2026 4:22 PM - SEC Filing
Abbott’s dividend yield near decade peak, signaling rare buying opportunity
May 12, 2026 1:07 PM - StreetInsider
Goldman Makes Monthly Adjustment to Regional Directors' Cut List in US
May 1, 2026 5:14 AM - StreetInsider
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Moreland Mary K
April 29, 2026 5:09 PM - SEC Filing
Form SCHEDULE 13G ABBOTT LABORATORIES Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 4:44 PM - SEC Filing
Form 10-Q ABBOTT LABORATORIES For: Mar 31
April 29, 2026 4:06 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Conroy Kevin T
April 28, 2026 8:08 PM - SEC Filing
Form 3 ABBOTT LABORATORIES For: Apr 24 Filed by: Conroy Kevin T
April 28, 2026 7:59 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Stratton John G
April 28, 2026 7:45 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: STARKS DANIEL J
April 28, 2026 7:38 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Roman Michael F
April 28, 2026 7:21 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: O'Grady Michael
April 28, 2026 7:14 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: McKinstry Nancy
April 28, 2026 7:03 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: McDew Darren W
April 28, 2026 6:55 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Kumbier Michelle
April 28, 2026 6:46 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Gonzalez Patricia Paola
April 28, 2026 6:27 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Blount Sally E.
April 28, 2026 6:17 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Babineaux-Fontenot Claire
April 28, 2026 6:09 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Ahuja Nita
April 28, 2026 6:02 PM - SEC Filing
Abbott receives FDA clearance for AI-powered coronary imaging platform
April 28, 2026 9:02 AM - StreetInsider
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
April 28, 2026 9:02 AM - PR NewsWire
Form 144 ABBOTT LABORATORIES Filed by: Alpern Robert J
April 27, 2026 6:34 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 23 Filed by: Boudreau Philip P
April 27, 2026 5:35 PM - SEC Filing
Form 8-K ABBOTT LABORATORIES For: Apr 24
April 27, 2026 4:08 PM - SEC Filing
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
April 25, 2026 12:30 PM - PR NewsWire
Form S-8 ABBOTT LABORATORIES
April 24, 2026 4:08 PM - SEC Filing
Daiwa Securities Downgrades Abbott Labs (ABT) to Neutral (3)
April 22, 2026 3:47 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $106 at Leerink Partners
April 21, 2026 4:15 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $110; Bernstein: 'Good entry point, or value trap?'
April 20, 2026 7:23 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $143 at Barclays
April 20, 2026 4:00 AM - StreetInsider
Form 8-K ABBOTT LABORATORIES For: Apr 10
April 17, 2026 4:04 PM - SEC Filing
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
April 17, 2026 3:30 PM - PR NewsWire
Abbott Labs (ABT) PT Lowered to $115 at Piper Sandler After a 'Disappointing Q1'
April 17, 2026 9:48 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $115 at TD Cowen
April 17, 2026 9:34 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $130 at RBC Capital
April 17, 2026 9:22 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $110 at Bernstein SocGen Group
April 17, 2026 8:40 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $110 at JPMorgan
April 17, 2026 8:07 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $115 at Oppenheimer
April 17, 2026 7:24 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $120 at Benchmark on Updated Guidance
April 17, 2026 6:54 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $115 at Mizuho
April 17, 2026 6:34 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $120 at BofA Securities
April 17, 2026 6:16 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $108 at Citi
April 17, 2026 4:55 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $120 at Stifel Following Q1 Results
April 16, 2026 4:31 PM - StreetInsider
Abbott (ABT) 51K contracts, compared to its 90-day average of 15K contracts, share price down 5.3%
April 16, 2026 3:53 PM - StreetInsider
Leerink Partners on Abbott Labs (ABT): U.S. MedTech softness could be viewed unfavorably
April 16, 2026 11:57 AM - StreetInsider
Abbott shares dip on soft current-quarter guide; Q1 results in line
April 16, 2026 8:22 AM - StreetInsider
Form 8-K ABBOTT LABORATORIES For: Apr 16
April 16, 2026 7:37 AM - SEC Filing
Abbott trims 2026 profit forecast on Exact deal hit, shares fall
April 16, 2026 7:36 AM - StreetInsider
Abbott (ABT) Reports In-Line Q1 EPS; offers guidance
April 16, 2026 7:31 AM - StreetInsider
Abbott completes Exact Sciences acquisition, reports Q1 results
April 16, 2026 7:30 AM - StreetInsider
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
April 16, 2026 7:30 AM - PR NewsWire
Abbott (ABT) call put ratio 1.5 calls to 1 put into quarter results
April 15, 2026 10:42 AM - StreetInsider
TD Cowen: 'Abbott Labs (ABT) Stock Reaction Overdone'
April 13, 2026 8:33 AM - StreetInsider
Abbott Owes $17 Million Punitive Damages In Baby-formula Trial - Bloomberg
April 10, 2026 3:00 PM - StreetInsider
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
April 9, 2026 9:01 AM - PR NewsWire
Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs
April 9, 2026 5:55 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $144 at Barclays
April 8, 2026 3:49 AM - StreetInsider
Abbott Labs (ABT) PT Lowered to $134 at Evercore ISI
April 6, 2026 8:14 AM - StreetInsider
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Stratton John G
April 2, 2026 5:32 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Roman Michael F
April 2, 2026 5:24 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Gonzalez Patricia Paola
April 2, 2026 5:16 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Alpern Robert J
April 2, 2026 5:08 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Ahuja Nita
April 2, 2026 5:01 PM - SEC Filing
Abbott Labs (ABT) PT Lowered to $131 at BTIG
March 30, 2026 4:16 PM - StreetInsider
Abbott integrates precision oncology tests with Flatiron's OncoEMR platform
March 30, 2026 9:01 AM - StreetInsider
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
March 30, 2026 9:00 AM - PR NewsWire
Form SCHEDULE 13G/A ABBOTT LABORATORIES Filed by: VANGUARD GROUP INC
March 26, 2026 3:06 PM - SEC Filing
Abbott hosts conference call for first-quarter earnings
March 26, 2026 9:00 AM - PR NewsWire
Form 4 ABBOTT LABORATORIES For: Mar 23 Filed by: ORVILLE JACOB A
March 25, 2026 6:57 PM - SEC Filing
Form 3 ABBOTT LABORATORIES For: Mar 23 Filed by: ORVILLE JACOB A
March 25, 2026 6:47 PM - SEC Filing
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
March 24, 2026 8:01 AM - PR NewsWire
Form S-8 ABBOTT LABORATORIES
March 23, 2026 5:30 PM - SEC Filing
Form 8-K ABBOTT LABORATORIES For: Mar 23
March 23, 2026 8:54 AM - SEC Filing
Abbott completes acquisition of Exact Sciences
March 23, 2026 8:50 AM - StreetInsider
Abbott completes acquisition of Exact Sciences
March 23, 2026 8:50 AM - PR NewsWire
Abbott to close Exact Sciences acquisition on march 23
March 20, 2026 9:10 AM - StreetInsider
Abbott acquisition of Exact Sciences set to close on March 23, 2026
March 20, 2026 9:10 AM - PR NewsWire
Form ARS ABBOTT LABORATORIES For: Dec 31
March 13, 2026 4:02 PM - SEC Filing
Form DEFA14A ABBOTT LABORATORIES
March 13, 2026 4:02 PM - SEC Filing
Form DEF 14A ABBOTT LABORATORIES For: Apr 24
March 13, 2026 4:01 PM - SEC Filing
UBS Reiterates Buy Rating on Abbott Labs (ABT) on DD Medical Device Growth Sustainability
March 13, 2026 9:37 AM - StreetInsider
Abbott Labs (ABT) Reiterated at Buy by Benchmark After FreeDM Trial Results
March 13, 2026 7:12 AM - StreetInsider
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
March 12, 2026 8:00 AM - PR NewsWire
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
March 11, 2026 11:00 AM - PR NewsWire
Piper Sandler's Key Takeaways From CRT 2026
March 10, 2026 8:35 AM - StreetInsider
Form 8-K ABBOTT LABORATORIES For: Mar 09
March 9, 2026 4:22 PM - SEC Filing
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
March 9, 2026 8:18 AM - StreetInsider
Full Article List
